Groupe la Francaise’s Vigil Neuroscience VIGL Stock Holding History

Groupe la Francaise’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-120,000	Closed	-$954K	–	825
2025 Q2	$954K	Buy	+120,000	New	+$538K	0.02%	267

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Groupe la Francaise's VIGL Position: Q3 2025 in Review

Groupe la Francaise sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 120,000 shares — an estimated $954K sold.

Groupe la Francaise first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $954K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Groupe la Francaise reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Groupe la Francaise sold 120,000 Vigil Neuroscience shares in Q3 2025, an estimated $954K.
Groupe la Francaise first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Groupe la Francaise's Vigil Neuroscience position peaked at $954K in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Groupe la Francaise's 13F filing for Q3 2025, filed 13 Nov 2025.